• Register
  • Login

Iraqi Postgraduate Medical Journal

  1. Home
  2. Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

Copyrights and Licensing

Home

About Journal

Aim and Scope

Editorial Board

Peer Review Process

Copyrights and Licensing

Indexing and Abstracting

Plagiarism Policy

Author's Guide

Article processing charge (APC)

Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery

    Authors

    • Alaa Hussein Altaee
    • Raghad Hannon Shinenalsudani
,
  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

ABSTRACT:
BACKGROUND:
Renal failure is a disease characterized by loss of renal function and it affects all body systems.
Anasthesia for renal transplant recipient needs skill and care to manage the abnormal systemic presentation of patient.
Anesthetic plan is affected by renal failure and effects appear by anesthetic drugs choices, doses, and combination. This Anasthetic plan also affected by the cause of renal failure, drugs therapy, dialysis, and duration of disease.
OBJECTIVE:
To assess the effect of remifentanyl infusion on total dose of atracurium required during renal transplant surgery.
METHOD:
Between 1stJanuary-2011 to 1st February-2013, in renal transplant center, medical city-Baghdad-Iraq, and hundred patients had renal transplant. All patients had received midazolam (0.05Mcg/kg), fentanyl (1Mcg/kg), propofol sleeping dose (1-1.5mg/kg) and atracurium (0.6mg/kg) then intubated.
Fifty patients were maintained with isoflurane (0.5-1 MAC), boluses of atracurium. Other fifty had same maintenance with addition of remifentanyl infusion using infusion pump in dose of (0.05-0.1Mcg).
RESULT:
Group with remifentanyl needed less dose of atracurium than group without remifentanyl. Mean dose for group with remifentanyl was (1.255mg/kg) while for group without remifentanyl was (1.623mg/kg).
Mean time for surgery in both groups was approximately equal, in group with remifentanyl time was (172.16min), and other group was (174.16min).
CONCLUSION:
Remifentanyl infusion decrease the dose of neuromuscular blocking agents required and may abolish it but blood pressure and pulse rate should monitored carefully.

Keywords

  • KEY WORDS
  • renal transplant
  • atracurium
  • isoflurane
  • XML
  • PDF 0 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 272
    • PDF Download: 163
Iraqi Postgraduate Medical Journal
Volume 13, Issue 1
March 2014
Page 99-102
Files
  • XML
  • PDF 0 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 272
  • PDF Download: 163

APA

Hussein Altaee, A., & Hannon Shinenalsudani, R. (2014). Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery. Iraqi Postgraduate Medical Journal, 13(1), 99-102.

MLA

Alaa Hussein Altaee; Raghad Hannon Shinenalsudani. "Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery". Iraqi Postgraduate Medical Journal, 13, 1, 2014, 99-102.

HARVARD

Hussein Altaee, A., Hannon Shinenalsudani, R. (2014). 'Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery', Iraqi Postgraduate Medical Journal, 13(1), pp. 99-102.

VANCOUVER

Hussein Altaee, A., Hannon Shinenalsudani, R. Remifentanyl Infusion Intraoperatively Decreased the Total Dose of Atracurium Required for Recipient in Renal Transplant Surgery. Iraqi Postgraduate Medical Journal, 2014; 13(1): 99-102.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

This work is licensed under          CC BY 4.0    

 

 

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by iJournalPro.com